|
Apr 25
|
Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Apr 25
|
20 Countries with the Highest Rates of Stomach Cancer in the World
|
|
Apr 23
|
Illumina (NASDAQ:ILMN) investors are sitting on a loss of 71% if they invested three years ago
|
|
Apr 21
|
This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger
|
|
Apr 19
|
20 Countries with the Highest Cancer Survival Rates in the World
|
|
Apr 19
|
Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?
|
|
Apr 19
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Apr 18
|
Engineering a Cool Career in Biotech - and Volunteering Along the Way
|
|
Apr 18
|
QQQ Has Some Inexpensive Growth Stocks
|
|
Apr 17
|
Evidence Supports Sequencing As First-Line Rare Disease Diagnostic
|
|
Apr 15
|
European Commission approves Illumina’s proposed Grail split
|
|
Apr 12
|
Illumina's planned divestment of GRAIL approved by the European Commission
|
|
Apr 12
|
UPDATE 1-EU approves Illumina's plan to divest cancer test maker Grail
|
|
Apr 12
|
EU approves Illumina's plan to divest cancer test maker Grail
|
|
Apr 10
|
Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure
|
|
Apr 10
|
Illumina CFO steps down amid executive shakeup
|
|
Apr 9
|
UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
|
|
Apr 9
|
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
|
|
Apr 9
|
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
|
|
Apr 5
|
Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late
|